INVO Fertility, Inc. (IVF) Research

INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.

Market snapshot

Symbol
IVF
Price
$1.50
Day change
-5.66%
Market cap
$2.1M
P/E ratio
-0.03x
52-week range
1.265-183.6
Sector
Healthcare
Industry
Medical - Devices
Analyst price target
$20.00

Peer companies

  • Avinger, Inc. (AVGR)
  • Accelerate Diagnostics, Inc. (AXDX)
  • CareMax, Inc. (CMAX)
  • Cutera, Inc. (CUTR)
  • NeuBase Therapeutics, Inc. (NBSE)
  • OncoSec Medical Incorporated (ONCSQ)
  • Oncternal Therapeutics, Inc. (ONCT)
  • Cassava Sciences, Inc. Warrant (SAVAW)

Recent insider activity

  • Krigsvold Terah Renee — trade (0 shares) on 2025-12-30
  • Krigsvold Terah Renee — trade (4375 shares) on 2025-12-30
  • Krigsvold Terah Renee — trade (2 shares) on 2022-12-29
  • Krigsvold Terah Renee — trade (11 shares) on 2025-12-30
  • Krigsvold Terah Renee — trade (2 shares) on 2023-01-13

Open INVO Fertility, Inc. (IVF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.